De la potentialisation des effets de la DOPA par les inhibiteurs de la monoamineoxydase
- 1 January 1966
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 8 (6) , 428-436
- https://doi.org/10.1007/bf00406491
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Interaction between imipramine-like agents and catecholamine-induced hyperthermiaJournal of Pharmacy and Pharmacology, 1965
- Role played by catechol and indolamines in the central actions of reserpine after monoaminoxidase inhibitionInternational Journal of Neuropharmacology, 1965
- A simple screening procedure for imipramine-like antidepressant agentsLife Sciences, 1963
- PHARMACOLOGICAL AND TOXICOLOGICAL PROPERTIES OF 2‐METHYL‐3‐PIPERIDINOPYRAZINE, A NEW ANTIDEPRESSANT*Annals of the New York Academy of Sciences, 1963
- Distribution and fate of dihydroxyphenylalanine-2-14C (dopa) in miceBiochemical Pharmacology, 1963
- ELECTROENCEPHALOGRAPHIC STUDIES ON THE ACTION OF RESERPINE, 3, 4-DIHYDROXYPHENYLALANINE AND 5-HYDROXYTRYPTOPHANE IN REFERENCE TO THE EFFECTS OF PRETREATMENT WITH BETA-PHENYLiSOPROPYLHYDRAZINEThe Japanese Journal of Pharmacology, 1962
- Effect of l-DOPA and N-Methyl-N-benzyl-2-propynylamine.HCl on DOPA, dopamine, norepinephrine, epinephrine and serotonin levels in mouse brainBiochemical Pharmacology, 1961
- PHARMACOLOGY OF IPRONIAZID AND OTHER AMINE OXIDASE INHIBITORSAnnals of the New York Academy of Sciences, 1959
- 3,4-Dihydroxyphenylalanine and 5-Hydroxytryptophan as Reserpine AntagonistsNature, 1957
- THE MEASUREMENT OF THE INFLUENCE OF DRUGS ON VOLUNTARY ACTIVITY IN MICEBritish Journal of Pharmacology and Chemotherapy, 1953